https://colforsin.com/index.ph....p/any-cmm-based-meth
To transport therapy effects seen in the Randomized Evaluation of Long-Term Anticoagulation trial, we applied inverse odds weights to standardize estimates to two Medicare target communities of great interest, initiators of (1) dabigatran and (2) warfarin. Individually, we carried out a non-experimental research within the Medicare communities making use of standard morbidity ratio weighting to control measured confounding. Results contrasting dabigatran to warfarin, estimated 2-year RDs for is
Aimer
Commentaire
Partagez
